Key Takeaways
- High-dose flu vaccines contain four times the antigen of standard formulations to prompt a stronger immune response.
- The CDC and ACIP preferentially recommend high-dose or adjuvanted flu vaccines for adults aged 65 and older.
- Immunosenescence — the natural age-related decline in immune function — is the core reason older adults need enhanced formulations.
- Both vaccine types are inactivated and require an annual shot due to changing influenza strains.
- Side effects from high-dose vaccines can be more noticeable but are generally mild and temporary.
- Always consult a healthcare provider to determine the appropriate formulation for your age and health status.
Option A
Standard-Dose Flu Shot
The widely available, age-appropriate choice for most adults.
Best for: Generally healthy adults under 65 who need annual influenza protection.
Option B
High-Dose Flu Vaccine
A stronger formulation designed to compensate for age-related immune decline.
Best for: Adults 65 and older whose immune systems produce weaker responses to standard vaccine formulations.
If you are a healthy adult under age 65
Standard-Dose Flu Shot
Standard formulations generate sufficient immune responses in younger adults and are widely available at most pharmacies and clinics each flu season.
If you are 65 years of age or older
High-Dose Flu Vaccine
Older immune systems respond less robustly to standard antigen levels; high-dose formulations are designed specifically to overcome this gap and reduce serious flu complications.
If you are unsure which vaccine applies to your health situation
High-Dose Flu Vaccine
For adults 65+, both the CDC and ACIP express a preference for enhanced formulations; your healthcare provider can confirm the right choice given your full medical history.
How the Two Vaccines Differ
Both the standard-dose and high-dose flu vaccines are inactivated influenza vaccines — meaning they contain killed virus particles rather than live ones. To understand the broader category, see our overview on live versus inactivated vaccine formulations.
The key distinction between the two is antigen concentration. Antigens are the viral proteins that prompt your immune system to build protective antibodies. A standard-dose flu vaccine contains 15 micrograms (mcg) of hemagglutinin antigen per strain. The high-dose formulation — marketed under the brand name Fluzone High-Dose Quadrivalent, though this article focuses on the category rather than any specific product — contains 60 mcg per strain, four times the standard amount.
This higher antigen load is specifically intended to produce a stronger antibody response in people whose immune systems no longer react as vigorously to vaccine stimulation — a phenomenon known as immunosenescence.
| Criterion | Standard-Dose Flu Shot | High-Dose Flu Vaccine |
|---|---|---|
| Antigen per strain | 15 mcg | 60 mcg |
| Recommended age group | Adults under 65 | Adults 65 and older |
| Vaccine type | Inactivated (killed virus) | Inactivated (killed virus) |
| ACIP preference status | Standard recommendation | Preferentially recommended for 65+ |
| Side effect intensity | Typically mild | Possibly more pronounced, still mild |
| Annual update required | Yes | Yes |
Why Age Changes the Equation
Immunosenescence is the gradual decline in immune function that accompanies aging. As the immune system ages, it produces fewer naïve T and B cells — the front-line responders that generate new antibodies in response to a vaccine. This means that even a well-formulated vaccine may trigger a more muted protective response in an older adult compared with a younger one.
For influenza specifically, this matters a great deal. Adults 65 and older account for the majority of flu-related hospitalizations and deaths in the United States each year, according to the CDC. Standard-dose vaccines, while effective in younger populations, may not generate sufficient antibody titers in older adults to provide the same level of protection.
Clinical evidence supports this distinction. A large randomized trial published in the New England Journal of Medicine found that high-dose influenza vaccine was approximately 24% more effective in preventing laboratory-confirmed influenza in adults 65 and older compared with standard-dose vaccine. To understand more about why immunity can differ so significantly by age, our article on why vaccine-induced immunity sometimes fades provides helpful context.
~24%
Greater efficacy of high-dose vs. standard-dose in adults 65+
A large randomized trial in the New England Journal of Medicine found high-dose flu vaccine reduced laboratory-confirmed influenza by approximately 24% more than standard-dose in this age group.
4×
Antigen concentration in high-dose vs. standard-dose vaccine
High-dose formulations contain 60 mcg of hemagglutinin antigen per strain compared with 15 mcg in standard-dose vaccines, designed to elicit a stronger immune response.
65+
Age group accounting for most flu-related hospitalizations
According to the CDC, adults aged 65 and older represent the majority of influenza-related hospitalizations and deaths in the United States each flu season.
Current Recommendations and What to Expect
The Advisory Committee on Immunization Practices (ACIP), which advises the CDC, preferentially recommends high-dose or adjuvanted flu vaccines for adults aged 65 and older. If these are unavailable, any approved influenza vaccine is considered better than none.
For adults under 65 without specific immune conditions, the standard-dose flu shot remains the appropriate and effective choice. Both vaccines are updated annually to reflect the influenza strains predicted to circulate in the coming season.
Regarding side effects: high-dose vaccines may produce more pronounced injection-site reactions — such as soreness, redness, or swelling — as well as mild systemic symptoms like fatigue or low-grade fever. These responses are generally short-lived and reflect the immune system mounting a response. They are not signs of illness caused by the vaccine itself, as the vaccine contains no live virus.
For a broader picture of which vaccines adults should discuss as they age, see our guide on vaccines your body may still need after age 50.
This article is for general informational and educational purposes only and does not constitute medical advice. Consult a licensed healthcare provider to determine the appropriate flu vaccine formulation for your individual health needs.